Comerica Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$29.6M Buy
241,435
+3,353
+1% +$407K 0.12% 147
2025
Q3
$26.4M Sell
238,082
-13,547
-5% -$1.54M 0.1% 191
2025
Q2
$27.9M Sell
251,629
-7,207
-3% -$767K 0.11% 172
2025
Q1
$29M Sell
258,836
-13,799
-5% -$1.42M 0.12% 157
2024
Q4
$25.2M Sell
272,635
-14,039
-5% -$1.26M 0.1% 180
2024
Q3
$24M Sell
286,674
-36,684
-11% -$2.8M 0.1% 200
2024
Q2
$22.2M Sell
323,358
-9,036
-3% -$603K 0.09% 200
2024
Q1
$24.3M Buy
332,394
+2,404
+0.7% +$185K 0.1% 172
2023
Q4
$26.7M Buy
329,990
+31,849
+11% +$2.48M 0.12% 149
2023
Q3
$22.3M Sell
298,141
-64,687
-18% -$4.98M 0.12% 157
2023
Q2
$80 Buy
+362,828
New +$28.9M 0.01% 130
2022
Q4
$23.9M Sell
280,386
-542
-0.2% -$42.9K 0.19% 89
2022
Q3
$19.4M Buy
280,928
+6,813
+2% +$430K 0.16% 101
2022
Q2
$17M Buy
274,115
+19,064
+7% +$1.18M 0.14% 117
2022
Q1
$16.2M Sell
255,051
-11,849
-4% -$757K 0.12% 142
2021
Q4
$18.4M Sell
266,900
-5,419
-2% -$373K 0.14% 128
2021
Q3
$18.3M Sell
272,319
-52,876
-16% -$3.71M 0.11% 163
2021
Q2
$23.3M Sell
325,195
-28,106
-8% -$1.88M 0.14% 118
2021
Q1
$23.1M Buy
353,301
+5,999
+2% +$387K 0.14% 118
2020
Q4
$23.2M Sell
347,302
-21,132
-6% -$1.28M 0.15% 109
2020
Q3
$22.4M Sell
368,434
-10,296
-3% -$714K 0.16% 98
2020
Q2
$28.9M Buy
378,730
+16,858
+5% +$1.29M 0.22% 79
2020
Q1
$28.8M Sell
361,872
-1,428
-0.4% -$98.7K 0.26% 69
2019
Q4
$23.3M Sell
363,300
-2,558
-0.7% -$167K 0.18% 101
2019
Q3
$24.1M Buy
365,858
+16,565
+5% +$1.08M 0.19% 93
2019
Q2
$23.4M Sell
349,293
-62,859
-15% -$4.14M 0.19% 95
2019
Q1
$27.8M Sell
412,152
-31,348
-7% -$2.08M 0.23% 78
2018
Q4
$30.9M Sell
443,500
-72,887
-14% -$5.09M 0.26% 63
2018
Q3
$37M Sell
516,387
-32,181
-6% -$2.43M 0.3% 51
2018
Q2
$42.3M Sell
548,568
-20,544
-4% -$1.45M 0.3% 53
2018
Q1
$42.4M Sell
569,112
-36,026
-6% -$2.86M 0.3% 50
2017
Q4
$49.2M Sell
605,138
-70,308
-10% -$5.34M 0.33% 51
2017
Q3
$51.3M Buy
675,446
+225,946
+50% +$17.3M 0.37% 44
2017
Q2
$33.4M Sell
449,500
-4,624
-1% -$308K 0.25% 67
2017
Q1
$31.1M Sell
454,124
-9,241
-2% -$650K 0.24% 70
2016
Q4
$33.9M Buy
463,365
+851
+0.2% +$63.3K 0.27% 58
2016
Q3
$35.2M Sell
462,514
-6,699
-1% -$544K 0.3% 54
2016
Q2
$37.2M Sell
469,213
-58,680
-11% -$5.21M 0.32% 49
2016
Q1
$51.9M Sell
527,893
-15,841
-3% -$1.43M 0.46% 34
2015
Q4
$52.4M Sell
543,734
-14,122
-3% -$1.47M 0.51% 31
2015
Q3
$54.8M Sell
557,856
-608,134
-52% -$67.5M 0.52% 30
2015
Q2
$137M Buy
1,165,990
+556,521
+91% +$60.8M 0.59% 20
2015
Q1
$59.8M Sell
609,469
-619,609
-50% -$62.9M 0.51% 27
2014
Q4
$116M Buy
1,229,078
+611,726
+99% +$63.3M 0.5% 27
2014
Q3
$65.7M Sell
617,352
-33,942
-5% -$3.32M 0.58% 23
2014
Q2
$54M Sell
651,294
-129,129
-17% -$10.1M 0.46% 31
2014
Q1
$55.3M Buy
780,423
+55,009
+8% +$4.31M 0.42% 35
2013
Q4
$54.5M Sell
725,414
-53,290
-7% -$3.71M 0.42% 38
2013
Q3
$49M Buy
778,704
+5,571
+0.7% +$333K 0.34% 50
2013
Q2
$39.6M Buy
+773,133
New +$40.3M 0.32% 51

Other funds holding GILD

Comerica Bank's GILD Position: Q4 2025 in Review

Comerica Bank increased its Gilead Sciences (GILD) stake by 1.4% in Q4 2025, buying an estimated $407K and bringing the position to 241,435 shares worth $29.6M. The position accounts for 0.12% of the portfolio, ranked #147.

Comerica Bank first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $137M in Q2 2015. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Comerica Bank held 241,435 shares of Gilead Sciences worth $29.6M as of Q4 2025.
  • Comerica Bank bought 3,353 Gilead Sciences shares in Q4 2025, an estimated $407K.
  • Gilead Sciences made up 0.12% of Comerica Bank's portfolio in Q4 2025, its #147 holding.
  • Comerica Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
  • Comerica Bank's Gilead Sciences position peaked at $137M in Q2 2015.
  • 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.